Literature DB >> 9618455

Ozonolysis for selectively depolymerizing polysaccharides containing beta-D-aldosidic linkages.

Y Wang1, R I Hollingsworth, D L Kasper.   

Abstract

The depolymerization of polysaccharides, particularly those containing acid-sensitive components, into intact constituent repeating units can be very difficult. We describe a method using ozonolysis for depolymerizing polysaccharides containing beta-D-aldosidic linkages into short-chain polysaccharides and oligosaccharides. This method is carried out on polysaccharides that have been fully acetylated whereby beta-D-aldosidic linkages are selectively oxidized by ozone to form esters, from which the polysaccharides are subsequently cleaved with a nucleophile. Ozone oxidation of aldosidic linkages proceeds under strong stereoelectronic control, and reaction rates depend on the conformations of glycosidic linkages. Thus, beta-D-aldosidic linkages with different conformations can have very different reaction rates even in the absence of substantial chemical differences. These rate differences allowed for very high selectivity in cleaving beta-D-linkages of polysaccharides. Several polysaccharides from group B Streptococcus and other bacterial species were selectively depolymerized with this method. The repeating units of the group B Streptococcus polysaccharides all contain an acid-sensitive sialic acid residue in a terminal position on a side chain and several beta-D-residues including galactose, glucose, and N-acetylglucosamine; however, with each polysaccharide, one type of linkage was more reactive than others. Selective cleavage of the most sensitive linkage occurs randomly throughout the polymer chain, yielding fragments of controllable and narrowly distributed sizes and the same repeating-unit structure. The average size of the molecules decreases exponentially, and desired sizes can be obtained by stopping the reaction at appropriate time points. With this method the labile sialic acid residue was not affected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618455      PMCID: PMC22569          DOI: 10.1073/pnas.95.12.6584

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  The chemical degradation of starch: old reactions and new frontiers.

Authors:  R I Hollingsworth
Journal:  Biotechnol Annu Rev       Date:  1996

2.  Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.

Authors:  L C Paoletti; D L Kasper; F Michon; J DiFabio; H J Jennings; T D Tosteson; M R Wessels
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Neonatal susceptibility and immunity to major bacterial pathogens.

Authors:  P Ferrieri
Journal:  Rev Infect Dis       Date:  1990 May-Jun

4.  Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.

Authors:  P W Anderson; M E Pichichero; E C Stein; S Porcelli; R F Betts; D M Connuck; D Korones; R A Insel; J M Zahradnik; R Eby
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

Review 5.  Acid-catalyzed hydrolysis of glycosides.

Authors:  J N BeMiller
Journal:  Adv Carbohydr Chem Biochem       Date:  1967       Impact factor: 12.200

6.  Structure of the type 5 capsular polysaccharide of Staphylococcus aureus.

Authors:  M Moreau; J C Richards; J M Fournier; R A Byrd; W W Karakawa; W F Vann
Journal:  Carbohydr Res       Date:  1990-07-01       Impact factor: 2.104

7.  Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

Authors:  S B Black; H R Shinefield; B Fireman; R Hiatt; M Polen; E Vittinghoff
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

8.  An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.

Authors:  L C Paoletti; D L Kasper; F Michon; J DiFabio; K Holme; H J Jennings; M R Wessels
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

9.  Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.

Authors:  M R Wessels; V Pozsgay; D L Kasper; H J Jennings
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

10.  A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; A Muñoz; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  7 in total

Review 1.  Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species.

Authors:  Jinyou Duan; Dennis L Kasper
Journal:  Glycobiology       Date:  2010-10-28       Impact factor: 4.313

2.  Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.

Authors:  E A Albanyan; M S Edwards
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism.

Authors:  Lori S C Kreisman; Julia H Friedman; Andreea Neaga; Brian A Cobb
Journal:  Glycobiology       Date:  2006-09-21       Impact factor: 4.313

4.  Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.

Authors:  W M Kalka-Moll; Y Wang; L E Comstock; S E Gonzalez; A O Tzianabos; D L Kasper
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.

Authors:  Hilde-Kari Guttormsen; Lawrence C Paoletti; Keith G Mansfield; Wojcieck Jachymek; Harold J Jennings; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

6.  Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation.

Authors:  Christopher D Velez; Colleen J Lewis; Dennis L Kasper; Brian A Cobb
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 7.  Impact and Control of Sugar Size in Glycoconjugate Vaccines.

Authors:  Giuseppe Stefanetti; Calman Alexander MacLennan; Francesca Micoli
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.